An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Express Worries
However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some professionals said the popularity for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.
Within minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious medical dangers”.
